A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Eli Lilly & CO stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 331,877 shares of LLY stock, worth $264 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
331,877
Previous 334,282 0.72%
Holding current value
$264 Million
Previous $303 Million 2.85%
% of portfolio
1.37%
Previous 1.46%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $1.86 Million - $2.31 Million
-2,405 Reduced 0.72%
331,877 $294 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $7.42 Million - $9.31 Million
-10,242 Reduced 2.97%
334,282 $303 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $1.14 Million - $1.53 Million
-1,925 Reduced 0.56%
344,524 $268 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $6.1 Million - $7.19 Million
-11,611 Reduced 3.24%
346,449 $202 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $1.24 Million - $1.71 Million
-2,854 Reduced 0.79%
358,060 $192 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $1.12 Million - $1.49 Million
3,186 Added 0.89%
360,914 $169 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $4.82 Million - $5.66 Million
-15,517 Reduced 4.16%
357,728 $123 Million
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $1.6 Million - $1.86 Million
-4,976 Reduced 1.32%
373,245 $137 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $24.4 Million - $27.9 Million
-82,463 Reduced 17.9%
378,221 $122 Million
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $2.3 Million - $2.7 Million
8,243 Added 1.82%
460,684 $149 Million
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $1.26 Million - $1.57 Million
5,389 Added 1.21%
452,441 $130 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $8.87 Million - $11 Million
-39,459 Reduced 8.11%
447,052 $124 Million
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $2.45 Million - $3.02 Million
11,062 Added 2.33%
486,511 $112 Million
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $13.3 Million - $17.2 Million
-73,742 Reduced 13.43%
475,449 $109 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $2.11 Million - $2.73 Million
12,815 Added 2.39%
549,191 $103 Million
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $13.7 Million - $18.1 Million
-104,778 Reduced 16.34%
536,376 $90.6 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $442,607 - $511,956
-3,027 Reduced 0.47%
641,154 $94.9 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $236,961 - $285,180
-1,737 Reduced 0.27%
644,181 $106 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $23.4 Million - $29 Million
196,916 Added 43.86%
645,918 $89.6 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $1.84 Million - $2.27 Million
17,171 Added 3.98%
449,002 $59 Million
Q3 2019

Nov 08, 2019

BUY
$106.79 - $116.16 $2.11 Million - $2.29 Million
19,743 Added 4.79%
431,831 $48.3 Million
Q2 2019

Aug 09, 2019

SELL
$110.79 - $129.32 $2.75 Million - $3.21 Million
-24,843 Reduced 5.69%
412,088 $45.7 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $6.69 Million - $7.87 Million
60,063 Added 15.94%
436,931 $56.7 Million
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $23.2 Million - $26 Million
-219,050 Reduced 36.76%
376,868 $43.6 Million
Q3 2018

Nov 05, 2018

SELL
$85.86 - $107.31 $18.3 Million - $22.9 Million
-213,400 Reduced 26.37%
595,918 $63.9 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $2.81 Million - $3.22 Million
37,096 Added 4.8%
809,318 $69.1 Million
Q1 2018

Apr 30, 2018

SELL
$74.21 - $87.6 $4.16 Million - $4.91 Million
-56,071 Reduced 6.77%
772,222 $59.7 Million
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $16.4 Million - $17.6 Million
200,753 Added 31.99%
828,293 $70 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $35 Million - $38.9 Million
454,385 Added 262.42%
627,540 $53.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
173,155
173,155 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.